Yu et al. demonstrated an increased expression of SYK in paclitaxel-resistant ovarian cancer cells and that paclitaxel in combination with the SYK inhibitor R406 increased apoptosis in vitro and impaired tumor growth in vivo [33]. The gene discussed is SYK; the disease is ovarian cancer.